#Diabetes #HealthcareInnovation #Pharma #GLP1 #MedicalAffairs #HealthTech #DigitalHealth #PrecisionMedicine #ObesityMedicine #PharmD #ClinicalResearch #PharmaniMedX To view or add a comment, sign in Thank you McClatchy Media and Woman's World featuring me in this article discussing the use of the Phenomix Sciences "MyPhenome test" to help predict response to GLP-1 medications for obesity treatment
Lot CP-5794631 was tested by an independent laboratory
These effects were more pronounced in individuals with elevated baseline metabolic biomarkers, such as hyperglycemia and hypo-HDL cholesterol.[14] This suggests that L-carnitine could serve as a valuable adjunct therapy in managing metabolic syndrome and its related risks
The good news is that, generally speaking, taking Mounjaro or other GLP-1 medications like Ozempic (semaglutide) and Wegovy (semaglutide) is not typically a disqualifying factor for plasma donation
Unlike its peptide peers, sermorelin operates by stimulating the release of growth hormone-releasing hormone (GHRH) from a vital region of our brain, the hypothalamus
Another prescription medication is metoclopramide (Reglan)
